Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiac Electrophysiology
How do you manage persistent left atrial appendage thrombus despite therapeutic anticoagulation on DOAC and prior history of warfarin use?
Would you need to wait for full resolution of LAA thrombus on TEE before considering a Watchman?
Related Questions
For how long would you hold anticoagulation before percutaneous left atrial appendage closure with Watchman or Amulet devices?
When would you consider using Ibutilide for rapid pharmacologic cardioversion of atrial fibrillation?
What are your preferred methods for QTc calculation for normal, tachycardic and bradycardic heart rates?
For elderly patients (i.e. older than 80) with only one documented episode of paroxysmal atrial fibrillation following a stress event (such as acute illness/steroid administration) and a CHADsVASc score greater than 1, how would you counsel them on the risks/benefits of anticoagulation and subsequent monitoring for afib recurrence?
What is your approach to patient selection for cardioneuroablation for vasovagal syncope?
What clinical parameters or CV imaging considerations would prompt you to consider AV nodal ablation for patients with cardiac amyloidosis and symptomatic atrial fibrillation?
How soon following pacemaker implantation can patients safely undergo elective cardioversion?
Would you consider PPM implantation for patients during their hospital stay following TAVR if they were to develop lengthening PR intervals and widening LBBB QRS duration exceeding 150ms afterwards?
What is your approach for de-escalation of antiarrhythmics for patients with a history of ventricular arrhythmias?
In people who have had a single detected episode of atrial fibrillation, but none documented subsequently, is there any consideration for increased thrombolembolic risk just from altered atrial architecture, impaired contractility?